About BioConsortia
BioConsortia is a company based in Davis (United States) founded in 2014.. BioConsortia has raised $56 million across 7 funding rounds from investors including Khosla Ventures, Square 1 Bank and Otter Capital. BioConsortia offers products and services including Nitrogen Fixation, Biostimulants, and Biopesticides. BioConsortia operates in a competitive market with competitors including Pivot Bio, Ginkgo Bioworks, NewLeaf Symbiotics, Kula Bio and Pluton Biosciences, among others.
- Headquarter Davis, United States
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioconsortia, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$56 M (USD)
in 7 rounds
-
Latest Funding Round
$15 M (USD), Series E
Apr 01, 2024
-
Investors
Khosla Ventures
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioConsortia
BioConsortia offers a comprehensive portfolio of products and services, including Nitrogen Fixation, Biostimulants, and Biopesticides. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Microbial solutions for natural nitrogen production in crops
Products to boost crop growth and stress resistance
Microbes for protecting crops from pests and fungi
Unlock access to complete
Funding Insights of BioConsortia
BioConsortia has successfully raised a total of $56M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $15 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series E — $15.0M
-
First Round
First Round
(07 Apr 2014)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series E - BioConsortia | Valuation | Otter Capital |
|
| Apr, 2023 | Amount | Series E - BioConsortia | Valuation | Otter Capital |
|
| Mar, 2019 | Amount | Series D - BioConsortia | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioConsortia
BioConsortia has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Square 1 Bank and Otter Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Otter Capital's activities.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture debt, treasury, and cash management services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioConsortia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioConsortia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioconsortia Comparisons
Competitors of BioConsortia
BioConsortia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot Bio, Ginkgo Bioworks, NewLeaf Symbiotics, Kula Bio and Pluton Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Crop inputs are supplied using beneficial plant bacteria for agriculture.
|
|
| domain | founded_year | HQ Location |
Manufacturer of microbial crop nutrition products
|
|
| domain | founded_year | HQ Location |
Assay-based microbial research services are offered for industrial applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioconsortia
Frequently Asked Questions about BioConsortia
When was BioConsortia founded?
BioConsortia was founded in 2014.
Where is BioConsortia located?
BioConsortia is headquartered in Davis, United States. It is registered at Davis, California, United States.
Is BioConsortia a funded company?
BioConsortia is a funded company, having raised a total of $56M across 7 funding rounds to date. The company's 1st funding round was a Series D of $8M, raised on Apr 07, 2014.
What does BioConsortia do?
BioConsortia was established in 2014 in Davis, United States, within the biotechnology sector focused on agriculture. Microbial technologies are utilized to create products that improve fertilizer efficiency, promote plant growth, and enhance traits such as tolerance to cold, wet conditions, salt, and drought. A proprietary platform based on high-throughput sequencing is applied to identify microbes that benefit plant performance. Operations center on developing these solutions for crop improvement.
Who are the top competitors of BioConsortia?
BioConsortia's top competitors include Ginkgo Bioworks, Pivot Bio and Kula Bio.
What products or services does BioConsortia offer?
BioConsortia offers Nitrogen Fixation, Biostimulants, and Biopesticides.
Who are BioConsortia's investors?
BioConsortia has 3 investors. Key investors include Khosla Ventures, Square 1 Bank, and Otter Capital.